GlassScriptPhysician profile
Axel W Joob
NPI 1225039738
$2,984.49
in general payments reported to CMS, 2019-2025
7 companies · $22.36 in 2025
The $22.36 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $137 · 2021: $1,881 · 2023: $128 · 2024: $525 · 2025: $22.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $525 · Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $525.00 |
| Food and Beverage | $150.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,507.09 | 2020-2024 | Imfinzi |
| Covidien LP | $203.22 | 2019-2020 | |
| Kerecis Limited | $102.29 | 2019 | |
| Intuitive Surgical, INC. | $97.08 | 2023 | Da Vinci Surgical System |
| Atricure, INC. | $31.01 | 2023 | |
| Merck Sharp & Dohme LLC | $22.36 | 2025 | Keytruda |
| Davol INC. | $21.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Axel Joob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.